Bain Capital Private Equity and Goldman Sachs have agreed to sell their majority stake in Carver Korea, a specialist cosmetics supplier, to Unilever in a deal worth EUR2.27 billion ($2.7 billion).
Sea, the Singapore-headquartered mobile internet and gaming platform formerly known as Garena, has filed to list on the New York Stock Exchange.
Bain Capital Private Equity-owned Rise Education, a China-based company that provides after-school English teaching and tutoring services, has filed to list on NASDAQ.
Ironbridge Capital has made a partial exit from Bravura Solutions, the Australia-based financial services administrator that raised A$148 million ($118 million) through a domestic IPO last November.
US-listed Chinese recruitment site 51Job has agreed to acquire a 60% stake in industry peer Beijing Lagou Network Technology, which is backed by Qiming Venture Partners and other VC investors, for $119 million.
Indian hotel chain Lemon Tree Hotels has filed for an IPO that will provide a partial exit for Warburg Pincus.
Planned partial exits for investors in Best Inc. were shelved as the Alibaba Group-backed Chinese logistics operator raised a lower-than-expected $450 million in its US IPO. The stock increased 5% on debut.
Zai Lab, a Chinese drug developer backed by several venture capital investors, gained 55% on its NASDAQ trading debut following a $150 million IPO.
The Carlyle Group has sold its approximately 46% stake in Coates Hire as Seven Group Holdings took full ownership of the Australian equipment-leasing business in a deal worth A$517 million ($418 million).
New Zealand’s Waterman Capital has exited its entire 50% stake in HealthLink, a local online services provider for the healthcare industry, to Ireland-based medical technology specialist Clanwilliam.
Next Capital has agreed to sell its controlling stake in Australia-based aged care business Infinite Care to Moelis Australia. The GP first invested in the company in December 2014.
China-based Qudian, previously known as Qufenqi, a VC-backed micro-lending services provider, has filed for an IPO on the New York Stock Exchange.
Zhong An Insurance, a Chinese online-only insurance business backed by Alibaba Group, Tencent Holdings and Ping An Insurance as well as several PE investors, is looking to raise HK$11.9 billion ($1.5 billion) through a Hong Kong IPO.
Shanghai Fosun Pharmaceutical has altered the terms of its acquisition of a majority stake in India-based Gland Pharma – a deal that will facilitate an exit for KKR – as part of a long-running battle to win regulatory approval.
SBI Life, the life insurance subsidiary of the State Bank of India (SBI) whose backers include KKR and Singapore’s Temasek Holdings, has filed for an IPO.
Secoo, a private equity-backed Chinese e-commerce platform that focuses on luxury goods, is looking to raise up to $114.8 million through a US IPO.
Exit activity in Australia has followed a boom and bust pattern in recent years. Investors are consequently cautious about near-term IPO potential but not inactive
J-Star has made a full exit from Japanese pet services business Three Arrows to domestic GP Création Capital, its co-investor on the original deal.
Australian mid-market GP Advent Partners has agreed to sell Integrated Packaging Group (IPG), an industrial and agricultural packaging business, to listed counterpart Pro-Pac in a deal worth A$177.5 million ($142.9 million).
The Carlyle Group has agreed to reduce its stake in Japan-listed manufacturing industry equipment supplier Tsubaki Nakashima from about 47% to 2.4%.
A string of private equity investors are set for partial exits as Best Inc, a Chinese logistics operator backed by Alibaba Group, looks to raise up to $1.07 billion in its New York Stock Exchange IPO.
Navis Capital Partners' bet on UK-based Cherry Valley Group seven years ago has paid off with a sale to two Chinese agribusiness investors
Singapore-based Armstrong Asset Management has secured a first exit from its Southeast Asia-focused cleantech fund, selling its entire stake in six solar projects controlled by Thailand’s Symbior Solar Siam.
KKR has acquired a majority stake in cosmetic treatments business Laser Clinics Australia (LCA) at a valuation of A$650 million ($515 million). The deal facilitates a partial exit for The Growth Fund.